fda drug shortage list semaglutide status january 2025 Declares of Novo Nordisk's Wegovy, Ozempic Over FDA Issues Order on Resolution

Clinical studies have demonstrated that sustained weight reductiontypically achieved through caloric restriction and increased physical activitycan lead to favourable changes in lipid parameters, including reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, alongside modest increases in high-density lipoprotein cholesterol (HDL-C)

So if the medication inside is the same, why separate brands

Obesity as well as type 2 diabetes are chronic conditions, so typically once a medication is started, its not stopped unless its replaced with something else

doi: 10.3390/medicina59071266

Market Scale and the Commercial Case for GLP-1 Innovation The commercial potential tied to GLP-1 therapies is expanding quickly

If you forget your injection on a warm counter overnight, kept it in an unheated garage, or accidentally froze it, err on the side of caution and request a fresh vial from your pharmacy